Health

Sleep ApneaExplainer

The Evidence Pack: How a Once-Nightly Pill Targets the Neuromuscular Root Cause of Sleep Apnea

Sleep Medicine Physicians 40%Pharmaceutical Developers 35%Patient Advocates 25%

3 sources · 28d ago

Sleep ApneaExplainer

The Evidence Pack: How a Once-Nightly Pill Targets the Neuromuscular Root Cause of Sleep Apnea

Sleep Medicine Physicians 40%Pharmaceutical Developers 35%Patient Advocates 25%

3 sources · 28d ago

Factlen ExplainerFamine Prevention

The Science of Famine Prevention: Decoding the UN's 2026 Global Hunger Hotspots Report

Humanitarian Agencies 45%Nutritional Scientists 30%Geopolitical Analysts 25%

2 sources · 28d ago

Factlen ExplainerType 1 Diabetes

The Evidence Pack: How the First Disease-Modifying Therapy Delays Type 1 Diabetes by Nearly Three Years

Clinical Immunologists 40%Pediatric Endocrinologists 35%Public Health Advocates 25%

5 sources · 28d ago

Factlen ExplainerType 1 Diabetes

The Evidence Pack: How the First Disease-Modifying Therapy Delays Type 1 Diabetes by Nearly Three Years

Clinical Immunologists 40%Pediatric Endocrinologists 35%Public Health Advocates 25%

5 sources · 28d ago

Factlen ExplainerObesity Medicine

FDA Approves CagriSema, the First Combination GLP-1 and Amylin Therapy for Weight Loss

Clinical Endocrinologists 40%Metabolic Researchers 35%Health Economists 25%

4 sources · 28d ago

Factlen ExplainerObesity Medicine

FDA Approves CagriSema, the First Combination GLP-1 and Amylin Therapy for Weight Loss

Clinical Endocrinologists 40%Metabolic Researchers 35%Health Economists 25%

4 sources · 28d ago

Factlen ExplainerAntibiotic Stewardship

Major Meta-Analysis Finds Echinacea Significantly Reduces Antibiotic Use for Respiratory Infections

Public Health Officials 41%Clinical Pharmacognosists 35%Pediatricians 24%

5 sources · 28d ago

Factlen ExplainerAntibiotic Stewardship

Major Meta-Analysis Finds Echinacea Significantly Reduces Antibiotic Use for Respiratory Infections

Public Health Officials 41%Clinical Pharmacognosists 35%Pediatricians 24%

5 sources · 28d ago

Factlen ExplainerStem Cell Therapy

The Evidence Pack: How the First Embryonic Stem Cell Therapy for Huntington's Disease Aims to Repair the Brain

Regenerative Medicine Researchers 40%Clinical Neurologists & Surgeons 30%Patient Advocacy Groups 30%

4 sources · 29d ago

Factlen ExplainerInfectious Disease

Landmark Trial Finds Safer, Equally Effective Antibiotics to Replace Standard Treatment for Deadly 'Golden Staph' Bloodstream Infections

Clinical Trial Investigators 40%Global Health Implementers 35%Evidence Synthesis 25%

5 sources · 29d ago

Factlen ExplainerInfectious Disease

Landmark Trial Finds Safer, Equally Effective Antibiotics to Replace Standard Treatment for Deadly 'Golden Staph' Bloodstream Infections

Clinical Trial Investigators 40%Global Health Implementers 35%Evidence Synthesis 25%

5 sources · 29d ago

Menopause CareExplainer

FDA Removes Major Boxed Warnings for Heart Disease and Cancer from Menopausal Hormone Therapy Labels

Menopause Specialists 40%Federal Health Agencies 35%Gynecologic Oncologists 25%

5 sources · 29d ago

Menopause CareExplainer

FDA Removes Major Boxed Warnings for Heart Disease and Cancer from Menopausal Hormone Therapy Labels

Menopause Specialists 40%Federal Health Agencies 35%Gynecologic Oncologists 25%

5 sources · 29d ago

Factlen ResearchLongevity Science

The Evidence Pack: How GLP-1 Receptor Agonists Reduce Biological Age on Epigenetic Clocks

Longevity Medicine Advocates 40%Clinical Skeptics 35%Trial Investigators 25%

4 sources · 29d ago

Factlen ResearchLongevity Science

The Evidence Pack: How GLP-1 Receptor Agonists Reduce Biological Age on Epigenetic Clocks

Longevity Medicine Advocates 40%Clinical Skeptics 35%Trial Investigators 25%

4 sources · 29d ago

PROTAC TherapiesExplainer

FDA Approves Veppanu, the First 'Protein Degrader' Therapy for Advanced Breast Cancer

Clinical Oncologists 40%Biotech Analysts 30%Patient Advocates 30%

6 sources · 29d ago

PROTAC TherapiesExplainer

FDA Approves Veppanu, the First 'Protein Degrader' Therapy for Advanced Breast Cancer

Clinical Oncologists 40%Biotech Analysts 30%Patient Advocates 30%

6 sources · 29d ago

Factlen ExplainerADHD Innovation

The Evidence Pack: How the First-in-Class NDSRI Centanafadine Treats ADHD Without Exacerbating Anxiety

Clinical Psychiatrists 40%Neuropharmacologists 30%Patient Advocacy Groups 30%

5 sources · 29d ago

Organ TransplantationMedical Breakthrough

One Year Later: The World's First Bladder Transplant Patient is Thriving

Surgical Innovators 35%Clinical Researchers 35%Patient Advocates 30%

5 sources · 29d ago

Organ TransplantationMedical Breakthrough

One Year Later: The World's First Bladder Transplant Patient is Thriving

Surgical Innovators 35%Clinical Researchers 35%Patient Advocates 30%

5 sources · 29d ago

Factlen ExplainerPeptide Therapy

The Evidence Pack: How the Anti-Aging Peptide Epitalon Works as it Clears a Major FDA Hurdle

Longevity Researchers 40%Regulatory Agencies 35%Endocrinologists 25%

6 sources · 29d ago

Factlen ExplainerPeptide Therapy

The Evidence Pack: How the Anti-Aging Peptide Epitalon Works as it Clears a Major FDA Hurdle

Longevity Researchers 40%Regulatory Agencies 35%Endocrinologists 25%

6 sources · 29d ago

Bundibugyo OutbreakClinical Trial

How Scientists Are Deploying Two Experimental Drugs Against the Rare Bundibugyo Ebola Strain

Public Health Coordinators 40%Virology Researchers 35%Biopharmaceutical Developers 25%

7 sources · 29d ago

Bundibugyo OutbreakClinical Trial

How Scientists Are Deploying Two Experimental Drugs Against the Rare Bundibugyo Ebola Strain

Public Health Coordinators 40%Virology Researchers 35%Biopharmaceutical Developers 25%

7 sources · 29d ago

Factlen ExplainerMetabolic Health

FDA Approves Foundayo, the First Oral GLP-1 Drug That Can Be Taken Without Food or Water Restrictions

Endocrinologists 40%Health Economists 30%Pharmacologists 30%

3 sources · 29d ago

FDA Grants Breakthrough Status to Single-Dose LSD Therapy for Generalized Anxiety

Major Immunotherapy Rollout Significantly Improves Survival for Women with Aggressive Cervical Cancer

The Evidence Pack: How Recent US Life Expectancy Gains Are Translating Entirely Into Healthy Years

The Evidence Pack: How a Once-Nightly Pill Targets the Neuromuscular Root Cause of Sleep Apnea

More in Health

The Evidence Pack: How a Once-Nightly Pill Targets the Neuromuscular Root Cause of Sleep Apnea

The Evidence Pack: How a Once-Nightly Pill Targets the Neuromuscular Root Cause of Sleep Apnea

The Science of Famine Prevention: Decoding the UN's 2026 Global Hunger Hotspots Report

The Evidence Pack: How the First Disease-Modifying Therapy Delays Type 1 Diabetes by Nearly Three Years

The Evidence Pack: How the First Disease-Modifying Therapy Delays Type 1 Diabetes by Nearly Three Years

FDA Approves CagriSema, the First Combination GLP-1 and Amylin Therapy for Weight Loss

FDA Approves CagriSema, the First Combination GLP-1 and Amylin Therapy for Weight Loss

Major Meta-Analysis Finds Echinacea Significantly Reduces Antibiotic Use for Respiratory Infections

Major Meta-Analysis Finds Echinacea Significantly Reduces Antibiotic Use for Respiratory Infections

The Evidence Pack: How the First Embryonic Stem Cell Therapy for Huntington's Disease Aims to Repair the Brain

Landmark Trial Finds Safer, Equally Effective Antibiotics to Replace Standard Treatment for Deadly 'Golden Staph' Bloodstream Infections

Landmark Trial Finds Safer, Equally Effective Antibiotics to Replace Standard Treatment for Deadly 'Golden Staph' Bloodstream Infections

FDA Removes Major Boxed Warnings for Heart Disease and Cancer from Menopausal Hormone Therapy Labels

FDA Removes Major Boxed Warnings for Heart Disease and Cancer from Menopausal Hormone Therapy Labels

The Evidence Pack: How GLP-1 Receptor Agonists Reduce Biological Age on Epigenetic Clocks

The Evidence Pack: How GLP-1 Receptor Agonists Reduce Biological Age on Epigenetic Clocks

FDA Approves Veppanu, the First 'Protein Degrader' Therapy for Advanced Breast Cancer

FDA Approves Veppanu, the First 'Protein Degrader' Therapy for Advanced Breast Cancer

The Evidence Pack: How the First-in-Class NDSRI Centanafadine Treats ADHD Without Exacerbating Anxiety

One Year Later: The World's First Bladder Transplant Patient is Thriving

One Year Later: The World's First Bladder Transplant Patient is Thriving

The Evidence Pack: How the Anti-Aging Peptide Epitalon Works as it Clears a Major FDA Hurdle

The Evidence Pack: How the Anti-Aging Peptide Epitalon Works as it Clears a Major FDA Hurdle

How Scientists Are Deploying Two Experimental Drugs Against the Rare Bundibugyo Ebola Strain

How Scientists Are Deploying Two Experimental Drugs Against the Rare Bundibugyo Ebola Strain

FDA Approves Foundayo, the First Oral GLP-1 Drug That Can Be Taken Without Food or Water Restrictions

Explore more topics